Main > ONCOLOGY (**) > Skin Cancer>Melanoma>MET *** > Treatment > Co: CH. N. Aldesleukin***
Co: CH. N. Aldesleukin***'s subsections
(*) USA Approval Year: 1998
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2006. 05.05
TradeMark
TradeMark Web-Site
Co: CH. N. Aldesleukin***'s products
This section has no products